Literature DB >> 24708100

Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE.

Roshini Fernando1, Ying Lu, Stephen J Atkins, Tunde Mester, Kari Branham, Terry J Smith.   

Abstract

CONTEXT: CD34(+) fibrocytes, bone marrow-derived progenitor cells, infiltrate orbital connective tissue in thyroid-associated ophthalmopathy, a manifestation of Graves' disease. In the orbit, they become CD34(+) fibroblasts and coexist with native CD34(-) fibroblasts. Fibrocytes have been shown to express TSH receptor and thyroglobulin.
OBJECTIVE: The objective of the study was to determine whether a broader repertoire of thyroid protein expression can be detected in fibrocytes and whether a common factor is responsible. DESIGN/SETTING/PARTICIPANTS: Fibrocytes and fibroblasts were collected and analyzed from healthy individuals and those with Graves' disease in an academic clinical practice. MAIN OUTCOME MEASURES: Real-time PCR, Western blot analysis, gene promoter analysis, cell transfections, and flow cytometric cell sorting were performed.
RESULTS: We detect two additional thyroid proteins expressed by fibrocytes, namely sodium-iodide symporter and thyroperoxidase. The autoimmune regulator (AIRE) protein appears necessary for this expression. AIRE expression in fibrocytes results from an active AIRE gene promoter and stable AIRE mRNA. Knocking down AIRE with a targeting small interfering RNA reduces the expression of these thyroid proteins in fibrocytes as well as the transcription factors paired box-8 and thyroid transcription factor-1. When compared with an unaffected first-degree relative, levels of these proteins are substantially reduced in fibrocytes from an individual with an inactivating AIRE mutation. Levels of AIRE and the thyroid proteins are lower in orbital fibroblasts from patients with thyroid-associated ophthalmopathy than in fibrocytes. However, when mixed fibroblast populations are sorted into pure CD34(+) and CD34(-) subsets, the levels of these proteins are dramatically increased selectively in CD34(+) fibroblasts.
CONCLUSIONS: Fibrocytes express four proteins, the aggregate expression of which was previously thought to be restricted to thyroid epithelium. These proteins represent the necessary molecular biosynthetic machinery necessary for thyroid hormone production. Our findings implicate AIRE in the promiscuous expression of thyroid proteins in fibrocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24708100      PMCID: PMC4079309          DOI: 10.1210/jc.2013-4271

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.

Authors:  M Zakarija; S Jin; J M McKenzie
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

2.  Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts.

Authors:  B Grubeck-Loebenstein; K Trieb; A Sztankay; W Holter; H Anderl; G Wick
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

3.  Extrathyroidal thyroxine formation in completely thyroidectomized rats.

Authors:  A Taurog; E S Evans
Journal:  Endocrinology       Date:  1967-05       Impact factor: 4.736

4.  Autoimmune regulator induced changes in the gene expression profile of human monocyte-dendritic cell-lineage.

Authors:  Niko Sillanpää; Camelia Gabriela Magureanu; Astrid Murumägi; Arja Reinikainen; Anne West; Aki Manninen; Maarit Lahti; Annamari Ranki; Kalle Saksela; Kai Krohn; Riitta Lahesmaa; Pärt Peterson
Journal:  Mol Immunol       Date:  2004-11       Impact factor: 4.407

5.  Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue.

Authors:  A Feliciello; A Porcellini; I Ciullo; G Bonavolontà; E V Avvedimento; G Fenzi
Journal:  Lancet       Date:  1993-08-07       Impact factor: 79.321

6.  Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes.

Authors:  T W Tao; P J Cheng; H Pham; S L Leu; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

7.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 8.  Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.

Authors:  Orsolya Dohán; Nancy Carrasco
Journal:  Mol Cell Endocrinol       Date:  2003-12-31       Impact factor: 4.102

9.  Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts.

Authors:  T J Smith; G D Sempowski; H S Wang; P J Del Vecchio; S D Lippe; R P Phipps
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

10.  Characterization of regulatory elements and methylation pattern of the autoimmune regulator (AIRE) promoter.

Authors:  Astrid Murumägi; Perttu Vähämurto; Pärt Peterson
Journal:  J Biol Chem       Date:  2003-03-21       Impact factor: 5.157

View more
  26 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

2.  Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.

Authors:  Gian Luca Bagnato; William Neal Roberts; Alessia Fiorenza; Chiara Arcuri; Rosaria Certo; Francesco Trimarchi; Rosaria Maddalena Ruggeri; Gian Filippo Bagnato
Journal:  Endocrine       Date:  2015-05-21       Impact factor: 3.633

3.  Response to Letter to the Editor: "Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy".

Authors:  Terry J Smith; Thomas S Scanlan; Roshini Fernando
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

Review 4.  TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.

Authors:  Terry J Smith
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

Review 5.  IGF1 receptor and thyroid-associated ophthalmopathy.

Authors:  Michelle Mohyi; Terry J Smith
Journal:  J Mol Endocrinol       Date:  2017-12-22       Impact factor: 5.098

6.  Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy.

Authors:  Roshini Fernando; Stephen J Atkins; Terry J Smith
Journal:  Endocrinology       Date:  2016-07-29       Impact factor: 4.736

7.  Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.

Authors:  Roshini Fernando; Ekaterina Placzek; Edmund A Reese; Andrew T Placzek; Samantha Schwartz; Aaron Trierweiler; Leslie M Niziol; Nupur Raychaudhuri; Stephen Atkins; Thomas S Scanlan; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

8.  Slit2 Modulates the Inflammatory Phenotype of Orbit-Infiltrating Fibrocytes in Graves' Disease.

Authors:  Roshini Fernando; Ana Beatriz Diniz Grisolia; Yan Lu; Stephen Atkins; Terry J Smith
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

Review 9.  Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

10.  Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.

Authors:  Nadine Dragin; Jacky Bismuth; Géraldine Cizeron-Clairac; Maria Grazia Biferi; Claire Berthault; Alain Serraf; Rémi Nottin; David Klatzmann; Ana Cumano; Martine Barkats; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.